Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Bowden Insider Profile
4 Followers
Christopher Bowden, CMO at Agios Pharma, holds 15.49K shares in Agios Pharma (Ticker: AGIO), holds ― shares in Viridian Therapeutics (Ticker: VRDN), holds 44.17K shares in Alaunos Therapeutics (Ticker: TCRT).
Christopher Bowden has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Christopher Bowden holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Christopher Bowden
Christopher Bowden's Trading History
Agios Pharma
Jun 22, 2021
CMO
Uninformative Sell
2.91M
$492.64K
Viridian Therapeutics
―
Director
―
―
Alaunos Therapeutics
Jun 24, 2022
Director
Uninformative Buy
―
$53.00K
List of latest transactions for each holding click on a transaction to see Christopher Bowden's performance on stock
You May Also Like
Christopher Bowden insider profile FAQ
What is the percentage of profitable transactions made by Christopher Bowden?
The percentage of profitable transactions made by Christopher Bowden is ―.
What is the average return per transaction made by Christopher Bowden?
The average return per transaction made by Christopher Bowden is ―.
What stocks does Christopher Bowden hold?
Christopher Bowden holds: AGIO, VRDN, TCRT stocks.
What was Christopher Bowden’s latest transaction?
Christopher Bowden latest transaction was an Uninformative Sell of $2.91M.
What was Christopher Bowden's most profitable transaction?
Christopher Bowden’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Christopher Bowden's role in Agios Pharma?
Christopher Bowden's role in Agios Pharma is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.